# Scientists uncover 'very detailed map' of an enzyme target for rare metabolic disease

> Researchers from Mount Sinai published a study in Science Advances that determined the crystal structure of an upstream enzyme involved in glutaric aciduria type 1 (GA1), a rare genetic neuro-metabolic disease. The disease results from GCDH gene deficiencies that cause toxic glutaric acid to build up in the brain. The study could help drugmakers develop small-molecule inhibitors targeting this enzyme.

- Date: 2026-11-17 · published 2026-11-18T00:11:07.151Z
- Category: report · region Global · magnitude low
- Page: https://feedsoft.ai/events/105686-scientists-uncover-very-detailed-map-of-an-enzyme-target-for-rare-metabolic
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

This is a biomedical research development with no direct link to feed grains, oilseeds, or animal-feed commodity supply, demand, or prices. It has no plausible effect on feed markets.

## Sources

- fiercebiotech.com: https://www.fiercebiotech.com/research/scientists-uncover-very-detailed-map-enzyme-target-therapies-rare-metabolic-disease

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
